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Abstract
Background: In South Africa the estimated incidence of all forms of tuberculosis (TB) for 2008 was 960/100000. It was
reported that all South Africans lived in districts with Directly Observed Therapy, Short-course. However, the 2011 WHO
report indicated South Africa as the only country in the world where the TB incidence is still rising.
Aims: To report the results of a TB prevalence survey and to determine the speed of TB case detection in the study
communities.
Methods: In 2005 a TB prevalence survey was done to inform the sample size calculation for the ZAMSTAR (Zambia South
Africa TB and AIDS Reduction) trial. It was a cluster survey with clustering by enumeration area; all households were visited
within enumeration areas and informed consent obtained from eligible adults. A questionnaire was completed and a
sputum sample collected from each adult. Samples were inoculated on both liquid mycobacterium growth indicator tube
(MGIT) and Lo¨wenstein-Jensen media. A follow-up HIV prevalence survey was done in 2007.
Results: In Community A, the adjusted prevalence of culture positive TB was 32/1000 (95%CI 25–41/1000) and of smear
positive TB 8/1000 (95%CI 5–13/1000). In Community B, the adjusted prevalence of culture positive TB was 24/1000 (95%CI
17–32/1000) and of smear positive TB 9/1000 (95%CI 6–15/1000). In Community A the patient diagnostic rate was 0.38/
person-year while in community B it was 0.30/person-year. In both communities the adjusted HIV prevalence was 25% (19–
30%).
Discussion: In both communities a higher TB prevalence than national estimates and a low patient diagnostic rate was
calculated, suggesting that cases are not detected at a sufficient rate to interrupt transmission. These findings may
contribute to the rising TB incidence in South Africa. The TB epidemic should therefore be addressed rapidly and effectively,
especially in the presence of the concurrently high HIV prevalence.
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Introduction
South Africa has high TB and HIV prevalence rates and has not
reported a country-wide TB prevalence survey since 1998 [1]. In
South Africa the estimated incidence of all forms of TB for 2008
was 960/100000 with an annualised increase in estimated
incidence from 1998–2008 of 6.4% [2]. In 2007 it was reported
that the total South African population lived in districts with
Directly Observed Therapy, Short-course (DOTS) [3] and the
National TB programme reported a 64% cure rate amongst new
smear positive cases for the same year [4].
In order to determine the TB burden, two TB prevalence
surveys have previously been done in communities in the Western
Cape Province of South Africa [5–6]. At the time of these surveys,
the Western Cape had the highest reported rate of all types of TB
cases in the country [4]. Den Boon [6] reported a bacteriologi-
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cally-confirmed TB prevalence of 10/1000 and a smear-positive
prevalence of 3/1000 in 2002. Wood [5] reported a point
prevalence of adult pulmonary TB cases of 25/1000 with a smear-
positive prevalence of 28/1000 in HIV-positive individuals and 2/
1000 in HIV-negative individuals in 2005.
This manuscript reports on the prevalence of tuberculosis and
the proportion of prevalent cases detected by the TB programme
in the Western Cape. In 2005 a survey was done in four
communities to inform the sample size calculation and logistical
planning for the ZAMSTAR (Zambia South Africa TB and AIDS
Reduction) trial, which evaluated the impact of intensified case
finding and household contact tracing [7]. Two communities were
selected in Zambia [8] and two in the Western Cape, South Africa.
The main aim of the analysis for this manuscript was to report on
the prevalence of TB in these communities prior to any
intervention and we used the indicator ‘patient detection rate’ as
a measure of the comprehensiveness of TB services.
Methodology
Ethics statement
Approval for the study was obtained from the Health Research
Ethics Committees of Stellenbosch University, the University of
Zambia and the London School of Hygiene and Tropical
Medicine. Participants gave written informed consent for enrol-
ment into the survey and for the collection of sputum and salivary
samples. Names of participants were used only on the consent
forms. Barcodes were used on questionnaires, sample containers
and results and linked data of individuals without using names.
Only the data manager could link the barcodes to participants’
contact information in order to revisit TB culture-positive
participants and refer them to the closest health facility.
Participants who were willing to have a salivary HIV test signed
a separate informed consent form, received voluntary counselling
and testing, and if HIV positive, were referred to the nearest
health facility according to the current standard guidelines.
Salivary sample results were barcoded and linked to the original
sputum samples.
Study setting
Population-based TB prevalence surveys were carried out in
two urban communities in 2005 located in the City of Cape Town.
They were purposefully selected for their adjacent location and
similarity to the intervention communities of the ZAMSTAR trial
as previously described [7]. Each community was served by one
TB diagnostic centre defined as a primary health care facility
where TB smear microscopy, culture and identification testing
were available and patients were diagnosed with and treated for
TB.
Community A was a densely populated community with 99%
black African residents, of whom 57% lived in shacks and 49%
Figure 1. Flow chart of participants included in the survey.
doi:10.1371/journal.pone.0058689.g001
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were employed [9]. In 2005 the TB notification rate in this sub-
district was 1612/100000 and the antenatal HIV prevalence was
33% [10]. Community B was geographically located in a different
sub-district and had a 98% ‘coloured’ population in 2005 of whom
61% lived in brick houses and 77% were employed. In 2005 the
TB notification rate in the sub-district was 782/100000 and the
antenatal HIV prevalence was 16% [10].
Table 1. Prevalence of culture-positive TB in the two communities, overall and by individual and household characteristics.
COMMUNITY A COMMUNITY B
Cluster, age, sex standardized
Cluster, age, sex
standardised
N TB Prev/1000* Prev/1000** 95% CI N TB Prev/1000* Prev/1000** 95% CI
Prevalence before
imputation
34 27 43 24 17 33
Prevalence after
imputation
2726 67 25 32 25 41 3536 79 22 24 17 32
Sex and age
Male
15–24 362 6 17 21 11 42 503 4 8 8 4 18
25–34 233 9 39 46 26 80 299 10 33 34 20 55
35–44 163 11 67 72 37 138 277 10 36 34 18 60
45–54 122 4 33 35 15 80 217 9 41 42 20 88
55+ 99 7 71 77 49 120 184 5 27 28 14 53
Female
15–24 603 12 20 23 14 36 599 13 22 22 13 36
25–34 448 9 20 24 14 42 396 10 25 26 13 51
35–44 334 5 15 19 8 44 432 12 28 29 16 53
45–54 185 3 16 19 6 57 360 3 8 9 3 26
55+ 177 1 6 6 1 48 269 3 11 11 3 34
ever TB
no 2308 46 20 26 19 34 2992 56 19 20 14 28
yes 404 21 52 69 38 123 538 23 43 45 25 78
missing 14 0 6 0
how many meals
less than 3 1243 39 31 40 30 53 1264 29 23 24 14 41
3 or more 1349 26 19 25 17 36 2105 46 22 24 16 35
missing 134 2 167 4
years in community
0–4 786 25 32 46 32 65 365 7 19 19 11 32
5–9 455 12 26 31 18 55 282 4 14 15 6 37
10–14 378 11 29 33 18 61 262 5 19 23 9 54
15–19 482 9 19 20 11 37 700 17 24 25 16 40
20–24 609 10 16 23 13 39 601 11 18 18 11 30
25+ 1299 34 26 29 18 45
missing 16 0 27 1
house hold items
0 353 13 37 51 29 90 136 5 37 45 18 111
1 392 12 31 43 17 105 163 9 55 48 27 85
2 467 15 32 43 29 63 386 18 47 50 32 77
3 1077 23 21 26 16 42 1679 35 21 22 16 31
.4 434 4 9 10 4 25 1172 12 10 13 7 24
missing 3 0
*without imputation of missing data.
**with imputation of missing data.
doi:10.1371/journal.pone.0058689.t001
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Study design
Enumeration areas (EAs) from the South African National
Census maps of 2001 [9] were randomly selected in each
community and placed in order of selection. EAs were included
until the target sample size of 5000 participants was reached, but
the final EA was completed even if the number went over 5000.
Within each EA, all households were visited and households that
consented to participate were included in the survey; thus this was
a cluster sample survey with clustering by enumeration area.
Within each household, all adult household members (aged
$15 years) who spent the previous night in the household were
enumerated and all were eligible for inclusion in the survey. When
adults were enumerated but not present at the first visit to their
household, two further visits were made to minimize selection bias
due to non-response. Trained research assistants obtained written
informed consent and interviewed adults using a structured paper-
based questionnaire. Variables of interest collected by the
questionnaire included age, sex, history of previous TB, number
of years resident in the community and socio-economic status
assessed by the number of household assets (radio, television,
refrigerator, bicycle, car) and the number of meals eaten per day.
A sputum sample was requested from each participant. The
sample was collected on the spot either spontaneously or with the
assistance of breathing techniques.
HIV-prevalence was determined in 2007 on a random subset of
the TB prevalence participants. Ethics approval for anonymous
HIV testing with BIONORTM HIV-1&2 was not given prior to
the TB prevalence survey in 2005. After completion of the survey,
ethics approval was obtained for HIV testing under the condition
that a nurse qualified as a HIV-counsellor would test and refer
HIV-positive participants to access HIV care. HIV-prevalence was
therefore determined 18 months after the completion of the TB-
prevalence survey. Salivary samples were taken in 2007 from
traced participants.
Sample size calculation
WHO estimated a TB prevalence of 670/100 000 in South
Africa in 2004 [11]. Using the sample size calculated for the
primary outcome of the ZAMSTAR trial, which was TB
prevalence in the 24 communities included in the trial at the
end of the intervention period [7], 5000 adults per community had
to be enrolled. However, because of the much higher TB
prevalence found while doing the field work, fewer participants
were needed to be included in the sample. For the HIV-prevalence
at an estimated HIV seroprevalence of 25% and to achieve 5%
precision, the calculated sample size was 610 adults from each
community.
Laboratory measurements for TB
Samples were barcoded and transported in cooler boxes to the
laboratory. An unstained direct sputum smear was stored for each
sputum sample. Samples were then decontaminated and each
sample inoculated on both a liquid mycobacterium growth
indicator tube (MGIT) (BD, Sparks, USA) and a solid Lo¨w-
enstein-Jensen (LJ) culture according to standard WHO recom-
mendations. If a MGIT culture was contaminated, the sample was
decontaminated again and the culture was repeated using MGIT.
Laboratory cross-contamination was investigated as previously
described in the Zambian communities [8]. Spoligotyping was
done on any sputum samples that had positive cultures that were
inoculated on the same day.
The original smear was stained with Ziehl-Neelsen if mycobac-
teria grew on any culture media. Smears of individuals with a
negative culture were not examined. The GenoTypeH Mycobac-
terium CM/AS (Hain, Nehren) test was used to identify the species
of positive cultures. Laboratory quality was assured for smears by
re-reading of the samples by two individuals blinded to the
outcome. Drug susceptibility testing was done on culture positive
samples with GenoTypeH MTBDRplus (Hain, Nehren).
Laboratory measurements for HIV
BIONORTM HIV-1&2 salivary test kits (BIONOR AS, Nor-
way) were used to collect saliva in the field from participants
identified for HIV testing. The collection kits were transported
daily to the laboratory where HIV testing was done according to
the BIONOR algorithm.
Case definitions
A culture-positive prevalent pulmonary TB case was defined as
an adult who had a positive culture on either medium identified as
M.tuberculosis species with the GenoTypeH Mycobacterium CM/
AS. A smear positive TB case was defined as an adult with a
positive culture identified as M.tuberculosis (M.tb) and a direct smear
indicating acid fast bacilli. M.tb culture-positive participants were
revisited within six weeks after the initial visit and were referred for
treatment to the local TB clinic after a follow-up questionnaire, the
collection of two confirmatory sputum samples for smear and
culture and chest x-rays. The same clinical algorithm was used as
in the Zambian communities [8].
For study purposes a participant was defined as HIV positive
according to the BIONOR algorithm which included a confir-
matory test. Participants were counselled and tested voluntarily
according to current South African guidelines at the time and
referred to the nearest health facility for HIV care if HIV positive.
Indicator of comprehensiveness of services
The patient diagnostic rate [12] was estimated for each
community as the ratio of the notification rate for all pulmonary
tuberculosis cases (including retreatment cases) and the age-sex
standardised prevalence rates of culture positive tuberculosis cases
as estimated from the prevalence survey. Confidence intervals for
the patient diagnostic rate were approximated using the Delta
method.
Statistical methods
Data were analysed with STATA 12 (StataCorp LP, College
Station, TX, USA). For each community, pulmonary TB point
prevalence and 95% confidence intervals were estimated using a
logistic regression model with robust standard errors to adjust for
clustering at enumeration area level, inverse probability weighting
to standardise for age and sex and multiple imputation of missing
values on culture-positive TB, as recommended by the WHO [1].
For multiple imputation of missing values, the imputation model
included all the variables that were investigated as predictors of
culture-positive TB in the multivariable regression model and
fifteen imputed datasets were created. Inverse probability weight-
ing was used to account for age-sex differentials in survey
participants, and standardisation was to the age-sex structure of
the community according to the 2001 census [9]. The design effect
for a cluster sample survey, defined as ‘‘the multiple by which the
sample size must be increased compared to the sample size
required if simple random sampling was used, to ensure that the
estimate of the population prevalence is as precise as that which
would have been obtained from a simple random sample survey’’
[1], was calculated as the ratio of the variance taking into account
the cluster design and the variance ignoring the cluster design [13].
Based on this model, significant predictors of culture-positive TB
TB Prevalence and Case Detection in South Africa
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(p,0.05) in univariable logistic regression were determined.
Subsequently, these predictors were included in a multivariable
logistic regression model using backwards stepwise selection. The
final model consisted of predictors with p,0.05 except for age, sex
and previous TB which were included a priori. HIV status was not
included in the multivariable model because it was measured at a
different time point (18 months after the TB prevalence survey)
and on a random subset of participants. HIV prevalence was
calculated separately for each community to give an indication of
background risk.
Results
Prevalence
In 36 enumeration areas, 7667 adults were enumerated in the
two study communities (Figure 1). 6296 adults consented to
participate and provided a sputum sample, of whom 5670 adults
had culture results and 242 had a positive culture (MGIT and/or
LJ). A total of 146 (60%) of the positive cultures were Mycobacterium
tuberculosis (M.tb). Forty-four (30%) patients with M.tb positive
cultures had smears which were direct smear positive. Since
patients with any positive culture result (either one of two MGITs
or LJ) were defined as culture positive, and because at least one
evaluable culture result was available for all participants for whom
the sputum sample was not lost, no sample was dropped because of
contamination of both cultures. The design effect for Community
A was 1.04 and for Community B 2.16.
Predictors of prevalent TB
Sixty-seven of the culture-confirmed M.tb cases were from
Community A giving a crude prevalence of culture confirmed TB
of 25/1000 (Table 1). The crude smear positive prevalence was
7/1000. After standardising for sex and age, accounting for
clustering by enumeration area and imputing missing data, the
culture prevalence was 32/1000 (95%CI 25–41/1000) and the
smear positive prevalence 8/1000 (95%CI 5–13/1000). The
increased adjusted prevalence was mainly the result of age/sex
standardisation and not of the imputation of missing data. The
prevalence was highest in males aged more than 55 years and
females 25–34 years. Age and sex were strong predictors of
prevalent TB (Table 2), as was previous TB (OR=2.58 95%CI
1.16–5.74), years in community (less TB in participants with
longer residence in the area, with overall p = 0.016) and number of
household items (less prevalent TB in participants with more
household items). Although the number of meals per day was a
predictor of prevalent TB in the univariable analysis (OR 0.61
95%CI 0.38–0.98), after controlling for age, sex, previous TB and
household assets, there was no longer evidence of an association
(OR=0.99 95%CI 0.49–2.01).
Seventy-nine cases were from Community B giving a crude
prevalence of culture confirmed TB of 22/1000. The crude smear
positive prevalence was 7/1000. After standardising for sex and
age, accounting for clustering by enumeration area, and imputing
missing data, the culture prevalence was 24/1000 (95%CI 17–32/
1000) and the smear positive prevalence 9/1000 (95%CI 6–15/
1000). The prevalence was highest in males aged 45–54 years and
females aged 35–44 years (Table 2). Age and sex were strong
predictors of prevalent TB, as was number of household items (less
prevalent TB in participants with more household items). 81% of
the community had $3 household items in comparison with 55%
in Community A. There was no evidence of an association
between number of meals per day and prevalent TB, in either
univariable or multivariable analysis.
HIV background risk
In the sub-study investigating HIV status, 468 individuals were
enrolled in Community A, of whom 17 were TB cases as defined
in the TB prevalence survey and 109 were HIV positive. The age,
sex and cluster adjusted HIV prevalence was 25% (95%CI 19–
30%) among non-TB cases. In Community B, 672 individuals
were enrolled of whom 36 were TB cases and 166 were HIV
positive. The age, sex and cluster adjusted HIV-prevalence was
25% (95%CI 19–30%) among non-TB cases.
Patient diagnostic rate
In Community A the patient diagnostic rate was 0.38 per
person-year (Table 3). The patient diagnostic rate was 0.9 per
person-year among smear positive and 0.11 per person-year
among smear-negative patients. In Community B the patient
diagnostic rate was 0.30 per person-year. The patient diagnostic
rate was 0.59 per person-year among smear positive and 0.04 per
person-year among smear-negative patients.
Spoligotyping of M.tb strains
Spoligotyping showed that samples collected and prepared for
culture on the same day were similar in 12 samples on 6 separate
days (2 per day). Six of these samples were Beijing strain, four were
F11 strain and two Haarlem strain. Although the possibility exists
that these samples may have been cross contaminated giving a
contamination proportion of 6 out of 242 positive cultures (2.5%),
the laboratory methodology used (spoligotyping) could not
Table 3. Estimates of patient diagnostic rates for pulmonary tuberculosis.
Population
(a) Notification rate of PTB/1000
Population
(b) Prevalence of PTB/1000
Population
(a)/(b) Patient Diagnostic
Rate* 95% Confidence Interval
Community A
Smear Positive 7.73 8.60 0.90 0.47–1.33
Smear Negative 2.12 20.22 0.11 0.08–0.13
Total 12.31 32.79 0.38 0.29–0.47
Community B
Smear Positive 4.57 7.75 0.59 0.38–0.90
Smear Negative 1.37 37.95 0.04 0.03–0.05
Total 7.00 23.58 0.30 0.20–0.39
*Expressed as the number of cases detected per person-year among persons with PTB.
doi:10.1371/journal.pone.0058689.t003
TB Prevalence and Case Detection in South Africa
PLOS ONE | www.plosone.org 6 April 2013 | Volume 8 | Issue 4 | e58689
differentiate between substrains of Beijing, F11 or Haarlem. It is
therefore also possible that these samples were not contaminated
but contained substrains commonly found in the South African
context. In addition, given that these are the most dominant
strains found in our communities, the probability also exists that
these were correctly identified and not contaminants.
Drug susceptibility testing
Of the 146 prevalent TB cases, 141 had drug susceptibility test
results and of these, six cases were isoniazid mono-resistant (4%),
one case was rifampicin mono-resistant (1%) and one case was
isoniazid and rifampicin resistant (1%). The rest of the samples
were sensitive to isoniazid and rifampicin.
Discussion
This paper reports a very high prevalence of culture positive
pulmonary TB in the communities studied. The patient diagnostic
rate was much higher for smear positive patients than for smear
negative patients, amongst whom it was very low.
The estimated TB prevalence according to the WHO [14] for
South Africa was 5/1000 in 2005. The prevalence of smear
positive and culture positive TB reported in both communities
were higher than the national estimates which could be explained
by the fact that high burden TB communities were purposefully
selected in accordance with the ZAMSTAR protocol. Neverthe-
less, this extremely high TB prevalence, which was measured with
high quality survey methods, is cause for concern, in particular
when taking into account the low patient diagnostic rate,
suggesting the services fail to detect a significant proportion of
TB cases. Moreover, the notification rates for both subdistricts
showed a steady increase in TB incidence [10,15], suggesting that
current services are not stemming the tide of TB in these
communities.
Given the limited geographical coverage of surveys in South
Africa, significant effort should be made to improve prevalent TB
data estimation in order to inform policymakers and implementers
of the TB programme, hence the planning of a national TB
prevalence survey by the National TB Programme of South
Africa. It is crucial to address the TB epidemic in South Africa
immediately and effectively since the latest WHO report [16]
indicated South Africa as the only country where TB incidence is
rising. The fact that the incidence is rising and the prevalence is so
high suggests an epidemic still on the upwards curve.
In Community A, the informal settlement with a dynamic
population, there was less TB in participants with longer residence
in the area. This may be a proxy indication of the influence of
intraregional migration on prevalent TB. However, migrants into
community A are mostly from the Eastern Cape [10] which has a
reported lower TB notification rate than the Western Cape. The
migration stream from the Transkei region in the Eastern Cape
has been the key demographic flow into the Western Cape and has
transferred large numbers of individuals and families from rural
areas. This migration stream deposits poor individuals and families
into the informal urban settlements surrounding Cape Town.
Given the known association between poverty and TB [17], this
group may be at high risk of developing TB.
In both communities the study estimated a low patient
diagnostic rate, suggesting that cases are not detected at a
sufficient rate to interrupt transmission. A patient diagnostic rate
of .1.17 indicates more than 70% of cases are detected as
proposed [18] as part of an effective DOTS strategy. However, the
heterogeneity between the two communities was also demonstrat-
ed by the higher patient diagnostic rate among smear-positive
patients in Community A (0.99 per person-year) compared to
Community B (0.50 per person-year). For Community A this is an
indication of a well functioning TB programme, although the
detection of smear-negative TB is still not ideal. Solutions could be
tailored to address this epidemic heterogeneity.
Communities included in this study thus had a higher TB
prevalence and poorer case detection than national estimates [4].
The introduction of GeneXpert (Cepheid, USA) which is currently
been rolled-out across South Africa may improve case finding.
While limited case detection may be an important contributor to
the high TB prevalence and may contribute to the rising incidence
of TB in South Africa, other factors may play a role as well, such
as inadequate treatment success (reported to be 70% in the 2007
WHO report [14] on the 2004 treatment cohort for the same time
period as this study).
Different risk groups were identified during the survey in the
two communities, specifically males of all ages, those having had
previous TB (as was found in a similar South African community
[6]) and those of lower socio-economic status (as indicated by
number of household items). While this confirms epidemiological
expectations, our findings do not identify clearly defined risk
groups for intensified case finding. Other Southern African surveys
[8,19] indicated previous TB as a risk factor only in HIV positive
individuals. The final outcome prevalence survey of the ZAM-
STAR trial will however inform on the proportion of prevalent TB
that is attributable to HIV infection in Western Cape since HIV
status was captured on an individual level.
With regards to the HIV prevalence in the communities, it was
expected that the prevalence survey would mirror the antenatal
care HIV prevalence as was reported by the provincial health
system. The antenatal HIV prevalence in the subdistrict of
Community A was 16% and for the subdistrict of Community B it
was 33% in 2005 [10]. However, according to the survey, HIV
prevalence was similar across the two communities: lower in
Community A, but higher than expected in Community B with
both communities’ survey HIV prevalence at 25%. This may be
an indication of subsets of HIV epidemics within the province,
with a HIV prevalence on the rise in some communities, but
already plateauing in other communities. An upwards trend in
HIV prevalence was illustrated [20] in both subdistricts from 2001
to 2004 with an increase in prevalence from 22% to 33% in the
Community A subdistrict and an increase of 5% to 15% in the
Community B subdistrict, thus also illustrating the heterogeneity of
the HIV epidemic within the Western Cape province, and
indicating significant increases in the HIV prevalence in both
the study subdistricts just prior to our study. This will undoubtedly
further exacerbate the already perilous situation of tuberculosis in
these communities.
Limitations
The most important limitation of the survey was that we could
not directly investigate HIV status as a predictor for prevalent TB.
However, the association between HIV and TB is well established.
As was recently recommended by the WHO [1], testing for HIV
should at least be included for all participants confirmed to have
TB and may be considered for a wider group of survey
participants in TB prevalence surveys, especially in settings where
the HIV prevalence is high in the general population and where
HIV testing is a routine service. It is strongly recommended that
the South African National TB Programme includes testing for
HIV offered to all participants as part of the planned national TB
prevalence survey.
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